Sinclair Research, a leading provider of nonclinical contract research services, today announced an agreement to acquire the assets of the GLP safety pharmacology business unit of CorDynamics, a premier provider of cardiovascular toxicology and safety pharmacology contract research services. In addition to being able to support safety pharmacology core battery assessments of cardiovascular, respiratory and central nervous systems as outlined in ICH S7A guidelines, Sinclair’s strategic partnership with CorDynamics brings many years of expertise in studying primary and secondary pharmacodynamic effects in vital organ systems, for a wide range of test materials, in multiple preclinical species.
Read the full article: Sinclair Research Announces Expansion into Safety Pharmacology Services with CorDynamics Partnership //
Source: https://www.businesswire.com/news/home/20200116005104/en/Sinclair-Research-Announces-Expansion-Safety-Pharmacology-Services